Skip to main content

Peer Review reports

From: Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014

Original Submission
27 Jun 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
9 Oct 2015 Editorially accepted
19 Oct 2015 Article published 10.1186/s12885-015-1756-1

You can find further information about peer review here.

Back to article page